CS223449B1 - Method of preparation of the 5-aryl-7-chlor-1,3dihydro-1,4-benzodiazepine - Google Patents
Method of preparation of the 5-aryl-7-chlor-1,3dihydro-1,4-benzodiazepine Download PDFInfo
- Publication number
- CS223449B1 CS223449B1 CS417082A CS417082A CS223449B1 CS 223449 B1 CS223449 B1 CS 223449B1 CS 417082 A CS417082 A CS 417082A CS 417082 A CS417082 A CS 417082A CS 223449 B1 CS223449 B1 CS 223449B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- product
- filtered
- washed
- chloro
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 9
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052801 chlorine Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims 2
- 239000012043 crude product Substances 0.000 claims 2
- 238000002844 melting Methods 0.000 claims 2
- 230000008018 melting Effects 0.000 claims 2
- KFUPVMCNARYHKM-UHFFFAOYSA-N 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepine-2-thione Chemical compound C12=CC(Cl)=CC=C2NC(=S)CN=C1C1=CC=CC=C1Cl KFUPVMCNARYHKM-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 238000007605 air drying Methods 0.000 claims 1
- 239000000460 chlorine Chemical group 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- CHIFCDOIPRCHCF-UHFFFAOYSA-N delorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl CHIFCDOIPRCHCF-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 6
- VKCLPVFDVVKEKU-UHFFFAOYSA-N S=[P] Chemical compound S=[P] VKCLPVFDVVKEKU-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 2
- ULILTJWAJZIROM-UHFFFAOYSA-N 7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione Chemical compound C12=CC(Cl)=CC=C2NC(=S)CN=C1C1=CC=CC=C1 ULILTJWAJZIROM-UHFFFAOYSA-N 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 230000001670 myorelaxant effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Vynález se týká způsobu přípravy 5-aryI-7-chlor-l,3-dihydro-l,4-benzodiazepin-2-thionů obecného vzorce I, popsány a připravují se reakcí 5-aryl-7-chlor-l,3-dihydro-l,4-benzodiazepin-2-nů obecného vzorce II,The invention relates to a process for the preparation of 5-aryl-7-chloro-1,3-dihydro-1,4-benzodiazepine-2-thiones of the general formula I, described and prepared by the reaction of 5-aryl-7-chloro-1,3-dihydro - 1,4-benzodiazepin-2-ones of formula II,
ve kterém R značí atom vodíku nebo atom chloru.wherein R represents a hydrogen atom or a chlorine atom.
Látky obecného vzorce I mají jednak samy o sobě psychotropní účinnost (centrálně tlumivou, anxiolytickou, myorelaxační a protikřečovou), jednak jsou použitelné jako meziprodukty pro výroby dalších psychotropně účinných léčiv, zejména látek ze sérieThe compounds of the formula I have, on the one hand, psychotropic activity (centrally depressing, anxiolytic, myorelaxant and anticonvulsant), and, on the other hand, they are useful as intermediates for the production of other psychotropically active drugs, in particular substances of the series
6-aryl-8-chlor-4H-s-triazolo (4,3-a) -1,4-benzodiazepinů (Moffett R. B., Lectures Heterocycl. Chem, 3, S-123, 1976).6-aryl-8-chloro-4H-s-triazolo (4,3-a) -1,4-benzodiazepines (Moffett R. B., Lectures Heterocycl. Chem., 3, S-123, 1976).
Látky obecného vzorce I byly v literatuře ve kterém R značí totéž jako ve vzorci I, se sulfidem fosforečným ve vroucím pyridinu (Archer G. A. a Sternbach L. H., J. Org. Chem. 29, 231, 1964; Hester J. B. jr., Rudzik A. D., Kamdar Β. V., J. Med. Chem. 14, 1078, 1971; US patenty 3 144 439 a 3 243 427). Pro všechny literární prameny je charakteristické, že uvádějí relativně nízké výtěžky na žádaných produktech, které se pohybují od 35 41 °/o. Dále je typické, že popisované postupy používají ekvimolekulární poměr reagujících komponent, tj. látek vzorce II a sulfidu fosforečného: na 1 molekulu látky vzor223449 ce II se tedy používá 1 molekula sulfidu fosforečného.The compounds of formula I were in the literature in which R is the same as in formula I, with phosphorus pentasulfide in boiling pyridine (Archer GA and Sternbach LH, J. Org. Chem. 29, 231, 1964; Hester JB Jr., Rudzik AD, Kamdar, V., J. Med. Chem., 14, 1078, 1971; U.S. Patents 3,144,439 and 3,243,427). All literature sources are characterized by having relatively low yields on the desired products ranging from 35 to 41%. Furthermore, it is typical that the disclosed methods employ an equimolecular ratio of the reacting components, i.e., compounds of formula II and phosphorus sulphide: thus, 1 molecule of phosphorus sulphide is used per molecule of formula 223449.
Při bližším studiu přípravy látek vzorce I právě uvedenou reakcí bylo nyní zjištěno, že použije-li se přebytku sulfidu fosforečného, dochází k snížení výtěžků. Dále bylo učiněno překvapující zjištění, že při použití méně ně než ekvimolekulárního· množství sulfidu fosforečného dochází naopak k zvýšení výtěžnosti. Je to zřejmě způsobeno tím, že v molekule sulfidu fosforečného se při uvedené reakci uplatňuje více než 1 atom síry z 5 přítomných atomů tohoto prvku. Množství sulfidu fosforečného lze snížit až na polovinu ekvlmolekulárního množství při zachování vysoké výtěžnosti.Upon closer study of the preparation of the compounds of formula (I) by the above reaction, it has now been found that the use of excess phosphorus sulphide results in a reduction in yields. Furthermore, it was surprising to find that using less than an equimolecular amount of phosphorus pentasulfide, on the contrary, increases the yield. This is probably due to the fact that more than 1 sulfur atom out of the 5 atoms of this element is present in the phosphorus sulphide molecule. The amount of phosphorus pentasulfide can be reduced up to half the equimolar amount while maintaining a high yield.
Předmětem tohoto vynálezu je tedy způsob přípravy látek obecného vzorce I reakcí látek obecného vzorce II se sulfidem fosforečným ve vroucím pyridinu, při které se potíži je 50 až 90 % ekvlmolekulárního množství sulfidu fosforečného. Výhody tohoto postupu jsou zvýšení výtěžnosti prakticky na dvojnásobek proti údajům citované literatury, dále úspora relativně cenné výchozí látky a konečně snížení obtíží spojených s likvidací odpadů po provedení reakce (výhodné z hlediska nižšího znečištění odpadních vod a nižšího stupně zapáchajících a toxických exhalací).Accordingly, the present invention provides a process for the preparation of compounds of formula (I) by reacting compounds of formula (II) with phosphorus pentasulfide in boiling pyridine, wherein the problem is 50 to 90% of an equimolar amount of phosphorus pentasulfide. The advantages of this process are to increase the yield practically double that of the cited literature, to save a relatively valuable starting material, and finally to reduce the problems associated with waste disposal after the reaction (advantageous in terms of lower wastewater pollution and lower odor and toxic emissions).
PřikladlHe did
5-fenyl-7-chlor-l,3-dihydro-l,4-benzodiazepln-2-thion5-Phenyl-7-chloro-1,3-dihydro-1,4-benzodiazepine-2-thione
Směs 55,3 g (0,2 molu) 5-fenyl-7-chlor-l,3-dlhýdro-l,4-benzodlazepin-2-onu (DD patent 57 126), 22,2 g sulfidu fosforečného (0,1 molu) a 400 ml pyridinu se míchá a vaří 30 min. pod zpětným chladičem v dusíkové atmosféře. Potom se míchá bez zahřívání ještě 1 hodinu a po ochlazení se získaný roztok vlije do· míchaného roztoku 630 g chloridu sodného ve 2,1 1 vody. Směs se ochladí na 5 °C, přičemž vyloučený olejovitý produkt během 10 minut míchání zkrystalu-A mixture of 55.3 g (0.2 mol) of 5-phenyl-7-chloro-1,3-long-1,4-benzodlazepin-2-one (DD patent 57,126), 22.2 g of phosphorus sulphide (0, 1 mol) and 400 ml of pyridine are stirred and boiled for 30 min. under reflux in a nitrogen atmosphere. After stirring for 1 hour without heating, the cooled solution was poured into a stirred solution of 630 g of sodium chloride in 2.1 l of water. The mixture is cooled to 5 ° C, whereby the oily product precipitates in 10 minutes of stirring.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS417082A CS223449B1 (en) | 1982-06-04 | 1982-06-04 | Method of preparation of the 5-aryl-7-chlor-1,3dihydro-1,4-benzodiazepine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS417082A CS223449B1 (en) | 1982-06-04 | 1982-06-04 | Method of preparation of the 5-aryl-7-chlor-1,3dihydro-1,4-benzodiazepine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS223449B1 true CS223449B1 (en) | 1983-10-28 |
Family
ID=5383826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS417082A CS223449B1 (en) | 1982-06-04 | 1982-06-04 | Method of preparation of the 5-aryl-7-chlor-1,3dihydro-1,4-benzodiazepine |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS223449B1 (en) |
-
1982
- 1982-06-04 CS CS417082A patent/CS223449B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3635982A (en) | Amino-substituted-quinoxalinyloxazolidines and -oxazines | |
| US3819631A (en) | Azapurinones | |
| FI63409C (en) | REFERENCE FOR THERAPEUTIC TREATMENT OF THERAPEUTIC ANALYZA 1,5-DIHYDRO-IMIDAZO (2,1-B) QUINAZOLIN-2 (3H) -ONDERIVAT | |
| AU688295B2 (en) | 1,4-benzodiazepine derivatives and their use as CCK-modulators | |
| CA2057646A1 (en) | Benzodiazepinone | |
| Coburn et al. | Mesoionic purinone analogs. III. The synthesis and properties of mesoionic thiazolo [3, 2‐a] pyrimidine‐5, 7‐diones | |
| CZ280084B6 (en) | Derivatives of 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, process for their preparation and pharmaceutical preparation in which said derivatives are comprised | |
| US3422091A (en) | 5-phenyl-3h-1,4-benzodiazepine-2(ih)-thione and derivatives thereof | |
| CS223449B1 (en) | Method of preparation of the 5-aryl-7-chlor-1,3dihydro-1,4-benzodiazepine | |
| DE68921418T2 (en) | Imidazoquinoxalines and their preparation. | |
| US3870706A (en) | 6H-S-TRIAZOLO{8 4,3-a{9 {8 1,4{9 BENZODIAZEPIN-6-ONES | |
| Madroñero et al. | Synthesis of triazolo [4, 3‐d], tetrazolo [1, 5‐a]‐and quinazolino [3, 2‐d][1, 4] benzodiazepines | |
| Ait Itto et al. | Regioselective synthesis of new biheterocyclic triazepines | |
| US4022766A (en) | Pharmacologically active pyrrolodiazepines | |
| Schneller et al. | The Synthesis and Antiviral Properties of 8-Amino-3-[(2 hydroxyethoxy) methyl]-1, 2, 4-triazolo-[4, 3-a] pyrazine | |
| PL112570B1 (en) | Process for preparing novel 1,3-disubstituted derivatives of the urea or thiourea | |
| FI77032C (en) | PROCEDURE FOR FRAMSTAELLNING AV 6-PHENYL-11H-PYRIDO / 2,3-B // 1,4 / BENZODIAZEPINER. | |
| CA1047493A (en) | Benzodiazepine derivatives and a process for the preparation thereof | |
| US3849434A (en) | Process for preparing triazolobenzodiazepines | |
| SU784778A3 (en) | Method of preparing substituted 1-piperazinyl-4h-s-triazolo-/3,4-c/ thieno /2,3-e/ 1,4-diazepins | |
| Yoneda et al. | A synthesis of lumazine derivatives | |
| Glamkowski et al. | 7-(Aminoacyl) and 7-(aminoalkyl) derivatives of 1, 2, 6, 7-tetrahydroindolo [1, 7-ab][1, 5] benzodiazepines as potential antidepressant agents | |
| US3850951A (en) | Triazolobenzodiazepine 5n-oxide derivatives | |
| US3910926A (en) | Isoindolo {8 7,1,2-hij{9 quinolines | |
| US3842080A (en) | 7-phenylpyrimido(1,2-a)(1,4)benzodiazepin-1(5h)-ones |